Guotai Junan: The effectiveness and completion of the absorption and merger of Haitong Securities-related matters are still awaiting further review and approval by the boards of directors of both parties.
Jinshi data on October 11th, Guotai Junan issued an abnormal announcement. After the company’s self-inspection and written certification to the controlling shareholder and actual controller, it was confirmed that there is no other significant information that should be disclosed but not disclosed, except for the proposed stock swap and absorption of Hai Tong Securities and the raising of supporting funds already disclosed by the company. The effectiveness and completion of the relevant matters of this transaction are still subject to re-approval by the boards of directors of both parties, approval by the shareholders’ meeting of both parties, and approval, approval, registration, or consent of the competent regulatory authorities.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Guotai Junan: The effectiveness and completion of the absorption and merger of Haitong Securities-related matters are still awaiting further review and approval by the boards of directors of both parties.
Jinshi data on October 11th, Guotai Junan issued an abnormal announcement. After the company’s self-inspection and written certification to the controlling shareholder and actual controller, it was confirmed that there is no other significant information that should be disclosed but not disclosed, except for the proposed stock swap and absorption of Hai Tong Securities and the raising of supporting funds already disclosed by the company. The effectiveness and completion of the relevant matters of this transaction are still subject to re-approval by the boards of directors of both parties, approval by the shareholders’ meeting of both parties, and approval, approval, registration, or consent of the competent regulatory authorities.